In 2021, the Gates Foundation provided a US$4 million grant to the Kenyan medical device manufacturer Revital Healthcare to begin manufacturing auto-disable syringes in Africa.

Revital, which is based in Kilifi, Kenya, just outside the port city of Mombasa, is now on track to produce 300 million auto-disable syringes a year, a major step toward African self-reliance in supplying this vital commodity.

The first and only African company to be approved by the World Health Organization (WHO) to produce early-activation syringes, Revital is also powered by a workforce that is 80% female. 

Meet the Kenyan women making syringes for Africa

Videos ©Gates Archive/Kelvin Juma | Photos ©Gates Archive/Khadija Farah

The foundation’s grant to Revital was made to expand auto-disable syringe manufacturing in Africa to stabilize supply for routine immunization.

It intends to improve vaccine delivery.



“I told them, this is made in Kenya.”

On May 5th, 2024, UNICEF delivered the first shipment of Revital’s WHO-prequalified syringes to Niger.

Read next

Theo Sowa, Dr. Prime Josephine, and Dr. Awa Marie Coll Seck.

Three immunization advocates share why Gavi matters

Nearly 25 years after its founding, the global vaccine alliance has helped immunize more than 1 billion children.
By Violaine Mitchell Director, Immunization, Bill & Melinda Gates Foundation
A state health officer marks Muneerah Oyekan’s (9) finger to indicate that she’s received the HPV vaccine during the first phase of a country-wide HPV Vaccination Campaign targeting school-age girls between 9 and 14 years old in Lagos State, Nigeria, on November 3, 2023.

Four things to know about the single-dose HPV vaccine for cervical cancer

The single-dose HPV vaccine saves thousands of women's lives every year. Learn more about access for people to get the dose and effectiveness against cervical cancer.
By Anita Zaidi President, Gender Equality Division, Bill & Melinda Gates Foundation
Rachel Adams, Darlington Akogo, Dr. John Okombo, Dr. Disebo Potloane, Dandara Ramos, and Marie-Angélique Sène

Six scientists share the innovations that could transform the future

We asked scientists at the 2023 Grand Challenges Annual Meeting to share the scientific innovation that could transform their community over the next 20 years. Here’s what they said.